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1. 
Section 1 INTRODUCTION 
The first report of the possible existance of a glucose tolerance factor 
(GTF) was made by Mertz and Schwarz (1955) who noticed that a dietary 
additive, termed factor 3, isolated from an enzymatic casein hydrolysate 
(Schwarz (1952)), maintained normal glucose removal rates in diabetic-
like rats. These rats were the subject of a study on the development of 
dietary necrotic liver degeneration. The immediate cause of death,.in 
these rats, could be demonstrated to be severe hypoglycaemia (Mertz and 
Schwarz (1955)) that initially manifested itself, during the latent 
period of degeneration, as impairment of excess blood glucose removal. 
The diet used to induce the development of necrotic liver degeneration 
was a semi-purified, vitamin E-free, ration of 30% Torula yeast which 
also represented the sole protein source. The vitamin E prevented the 
development of necrotic liver degeneration but did not affect the removal 
of excess blood glucose. In 1957, Schwarz and Mertz reported that the 
factor 3, in itself, was not responsible for the maintainance of normal 
glucose removal rates but rather that it contained an active fraction 
separable by fractionation procedures involving evaporation, in vacuo, 
of a NaCl-containing, factor 3 concentrate. The NaCl was removed by 
filtration and the GTF activity was found to be present in the separated 
salt fraction, from which it could be removed by treatment with 65% 
ethanol. A further claim was made that this separated substance, now 
termed the glucose tolerance factor (GTF), not only prevented but cured 
impairment of glucose removal when administered in the diet and that 
the initial glucose impairment observed was not a symptom of necrotic 
liver degeneration but a result of a dietary deficiency. GTF prepara-
tions were reported (Mertz and Schwarz {1959)) to be routinely obtained 
from brewer's yeast as well as acid hydrolysates of dried, defatted, 
pork kidney powder. 
Identification of the active ingredient contained within the GTF 
preparations was then undertaken, with Schwarz and Mertz (1959) 
proposing that the active ingredient in the brewer's yeast extract was 
trivalent chromium. This proposal was initially based on the finding 
that wet-ashing of the GTF preparations did not remove the ability of 
the preparations to affect removal rates, indicating the presence of a 
2. 
trace element. After a series of screening tests, on various combina-
tions of trace elements components, it appeared that chromium was the 
common denominator in those combinations that exhibited a GTF-like 
response when administered as a dietary additive. Tests with various 
chromium compounds followed, resulting in the identification of Cr(III) 
compounds as those which, in general, showed effects similar to GTF 
preparations from brewers yeast (Schwarz and Mertz {1959}). Other 
methods were also used to attempt to isolate the active fraction from 
the brewer's yeast extract {Votava et!!_ {1973), Burkenholder and Mertz 
{1967)). Mertz et!!_ {1974), using their own separation procedure, 
claimed that their active fraction contained chromium, nicotinic acid, 
and amino acids and with no experimental evidence available relating to 
the structure of GTF, Mertz et!!_ proposed that GTF was a cationic 
Cr(III) complex with 2-axial N-coordinated, nicotinic acid ligands and 4 
amino acid ligands, possibly glycine, glutamic acid and cysteine, 
arranged in an undefined configuration. 
Toepfer et!!_ (1977} attempted to prepare a synthetic mixture with GTF-
like activity by mixing together a chromium (III) salt with nicotinic 
acid, glycine, glutamic acid and cysteine, on the assumption that a 
Cr(III) complex, such as that proposed by Mertz et!!_ (1974), would be 
formed. The resulting reaction mixture did show GTF-like activity, in 
their fat pad bioassay system, but nothing could be concluded about the 
nature of the complex or complexes responsible for the observed activity. 
This work was then extended by Cooper et!!_ (1984a,b) who synthesised 
defined Cr(III) complexes, firstly aquo-nicotinic acid complexes then 
various aqua-amino acid complexes. In each case the activity of the 
individual complexes were tested using a yeast bioassay system (Mirsky 
et!!_ (1980), Haylock et!!_ (1982)). The effect of N-coordination of 
the nicotinic acid ligands compared with a-coordination was studied 
along with a comparison of mono- and bidentate complexes of Cr(III) and 
nicotinic acid (Cooper et!!_ (1984a)). 
It was found that only the a-coordinated Cr(III) aquo-dinicotinic acid 
complex (fig. 1) showed any GTF-like activity. 
Fig~ Cr(m)(nic)i(r½O )Z~ 
not<2 trans arrangomon t 
of ligands. 
3. 
This was followed with a study on various amino acid complexes with the 
general structure Cr (amino acid)2(H2o)2 where the bidentate amino acid 
ligands were glycine, glutamic acid and glutamine. Also studied were, a 
solution of monodentate glycine aquo complexes and Cr-nicotinic acid-
glycine and Cr-nicotinic acid-cysteine complexes of undetennined 
structure (Cooper et!!_ (1984b)). The results showed that only 
Cr(glutamine) 2(H2o)2+,cr-nicotinic acid-glycine and the mixture of 
chromium glycine aquo complexes, showed any significant GTF-like 
activity in the yeast bioassay. From these results it was hypothesised 
that a trans arrangement, about the central metal ion, of the non-
coordinated nitrogen atoms in the ligands (fig 2) resulted in a 
structure with the ability to mimic the structure of natural GTF and was 
responsible for the observed activity. 
The acutal structure of GTF however, remained undetennined. 
Figure 2 Active Cr(III}-amino acid Complexes 
Note: arrangement of non-coordinated nitrogens 
compared with figure 1. 
4. 
In an attempt to finally detennine the structure of the GTF contained in 
brewer's yeast, Haylock et !l_ [(1983a)-Diagram l] subjected an 
autolysed, high chromium, conmercial yeast extract (Merck) to ion-
exchange columns, with varying pH gradients, resulting in the separation 
of 3 anionic, 4 cationic and 4 amphoteric fractions. 
Of these separated fractions only the 4 cationic fractions shovted any 
significant GTF-like activity in the yeast bioassay, and, of these 
biologically active fractions, only the fractions designated P3 and P4 
(diagram 1) were not attributable to complexing between chromium and 
the constituents of the growth medium. This was detennined (Haylock 
et !l (1983b)) by a comparison between the chromium containing fractions 
separated from: (i) harvested brewer's yeast cells grown on a medium 
containing added chromium chloride, (ii) the liquid remainder from the 
yeast growth in the high chromium medium, (iii) a control solution 
identical in all respects to the medium used for yeast growth except 
5. 
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that no yeast was added and (iv) the chromium-containing fractions 
separated previously from the high chromium commercial yeast extract 
(Merck). 
As only the fractions P3 and P4 (Haylock et~ (1983b))were not able to 
be isolated from the control solution it was decided that these must be 
a component of the yeast cells and therefore would be the most likely 
fractions to contain GTF. The fractions P3 and P4 were selected to 
undergo further purification using ion-exchange and gel-filtration 
chromatography. Only a small percentage of the chromium-containing 
material and all of the biological activity were retained on the cation-
exchange column, for both of the fractions P3 and P4, indicating a 
separation of biological activity and the chromium-containing material. 
Structural analysis of the biologically-active fractions followed ultra-
violet, and visible absorption and mass spectral analysis, which 
indicated the presence of tyramine in both of the separated fractions 
(ie. P3 and P4). However, accurate analysis of the P3 fraction was 
precluded as it was not found possible to separate the active material 
from the phosphate buffer used in the elution of this fraction from the 
cation-exchange column. 
The activity of tyramine was determined by both the yeast bioassay 
system (Haylock et~ (1983b)) and a rat adipocyte assay (E.M. 
Holdsworth, University of Tasmania, Personal Communication), however the 
tyramine was not found to be active in either assay system. 
The separation of biological activity and the majority of the chromium 
present in the separated fractions indicated that the activity observed 
was not due to the presence of chromium but rather to some other factor 
(Haylock et~ (1983b)). 
~urther work by J. Cooper (unpublished results), based on the procedure 
of Haylock et~ [(1983a)-Diagram 1], resulted in the separation of the 
active fraction of the Merck yeast extract, using a series of gel-
filtration and ion-exchange columns as follows: 
1 kg of yeast extract (Merck) was dissolved in water and loaded onto a 
Dowex 1-X8 column which bound and removed the anionic fraction 
7. 
(predetermined as being non-active (Haylock et!.!_ (1983a)). The filtrate 
was collected and loaded onto a Dowex 50W-X12 column and washed with 
water to remove the neutral portion (also predetermined as being 
inactive (Haylock et!.!_ (1983a)). The column, was then washed with a pH 
gradient generated in situ by the use of 0.6M NaH2Po4 (1000 cm3) versus 
0.2M Na2HP04 (1000 cm3) and finally eluted with 0.2M Na2HP04 (1000 cm3) 
until a pH of 9.0 was attained and then with 0.05M Na3Po4 (1000 cm3) 
until the pH was 12.0. The biological activity of the resulting 
cationic samples was determined using a yeast bioassay system (Mirsky et 
al (1980); Haylock et!.!_ (1982)). The fraction showing activity was 
loaded onto a Dowex 50W-X2 column and eluted using volatile buffers 
(e.g. NH4Hco3/NH40H.) The biological activity of the fractions was 
again determined and the active fractions collected, freeze dried and 
run through a Sephadex G-15 column to remove the salt. The biological 
activity was again followed and the active portion collected and freeze-
dried. The resultant, active, cationic fraction comprised 0.9g of 
yellowish solid, exhibited high biological activity and was essentially 
chromium-free. This fraction was then designated as 'yeast GTF' and 
will be referred to as such for the duration of this work. 
The selection of the assay system for determining GTF-like activity, in 
the samples under study, was primarily based on the requirement for an 
assay which was simple enough for use in a routine manner to screen 
large numbers of samples. 
The original assay for the presence of GTF was developed by Mertz and 
Schwarz (1959) and involved the induction of impaired glucose tolerance in 
rats by the administration of a controlled, vitamin E-free, diet of 
Torula yeast and sucrose. The test for the presence of GTF in a sample 
was to orally administer that sample to the rat and determine whether 
the rate of excess blood sugar removal returned to normal. 
Mertz et!.!_ (1961) developed a similar assay based again on the induction of 
impaired glucose tolerance in rats. A piece of rat epididymal adipose 
tissue, obtained from the diabetic-like rats, was incubated in a 
carbonate or Krebs-Ringer phosphate buffer, for 2 hours, with insulin, 
sample and carbon-14 labelled glucose. 
8. 
The 14co2 produced was absorbed in base and measured radiometrically. 
The biological activity generated by the test sample was determined by 
comparing the amount of 14co2 produced by the sample with that produced 
by insulin alone. This assay method was modified by Anderson et~ 
(1978) to account for variations between individual pieces of adipose 
tissue. The epididymal adipose tissue was digested with collagenase and 
the adipocytes were separated by flotation. Incubation of the 
adipocytes required the presence of 2% albumin in the Krebs-Ringer 
phosphate buffer to disperse the washed fat cells. 
The two assay methods outlined, while they are possibly the most specific 
methods available, require the growing and nurturing of the diabetic-
like rats, which is an expensive and time consuming process. The rats 
must be kept on a controlled diet, to induce impaired glucose tolerance, 
and kept in stainless steel free cages to prevent chromium from being 
absorbed by either eating or gnawing at the metal. The time required to 
run the assay means it is difficult for the assay to be used in a 
routine manner to screen a large number of samples for GTF-like activity. 
In this work, the assay system selected was a modification of a standard 
yeast bioassay system (Mirsky et~ (1980)). For this assay, three 
strains of yeast cells were individually grown for use in the bioassay 
(i.e. Saccharomyces carlsbergensis, Saccharomyces cerevisiae, Saccharo-
myces ellipsoideus). The fermentation rates of the yeast cells, in the 
presence of various test samples, as measured by Warburg manometric 
techniques (Manometric Techniques 3rd Ed.}, were used as the basis for 
detection of GTF-like activity in those samples. The fermentation rates 
observed, in the presence of added sample, were compared with the 
fermentation rates of a control solution which contained no added sample 
' but was identical in all other respects to the test sample solutions 
(i.e. a sample blank). A modification of this system (Haylock et~ 
(1982)) was a lowering of the cell count in the bioassay system from the 
orginal 3x108 cells/cm3 to l.Sx108 cells/cm3 in order to enhance the 
effects of any observed GTF-like activity in the test samples. The 
justification for the use of yeast cells to assay for the presence of a 
factor responsible for increased glucose removal from blood, was on the 
basis that as there appeared to be such a high concentration of GTF in 
yeast, there must be some physiological necessity for it in the cell. 
9. 
Thus it was originally assumed that external administration of GTF to a 
GTF deficient cell (i.e. it is assumed that Cr-free means it is GTF-
free) in the presence of glucose under anaerobic conditions, should have 
much the same effect as with blood and tissue cells in animals. If the 
sample supplied to the yeast cells did not facilitate glucose uptake, as 
seen by increased co2 production rates, then it was assumed that it was 
also unlikely to affect glucose removal rates from blood in mammals. 
At the beginning of this study the hypothesis fonnulated to account for 
the results of both Haylock (1983 a,b) and Cooper (1984 a,b) was that 
the activity of the yeast GTF was due to the presence of a peptide, or 
possibly an amino acid, with a specific arrangement of nitrogen atoms 
similar to that observed by Cooper (1984 a,b) in chromium-amino acid and 
chromium-nicotinic acid complexes (figs 1 and 2). To account for the 
observed cationic character of the yeast GTF fractions (Haylock et!!_ 
(1983 a,b)) it was presumed that amino acids with the greatest basic 
character were present, such as arginine and lysine, in the yeast GTF 
and also that such amino acids would be most likely to have an orienta-
tion of nitrogen atoms similar to that proposed by Cooper (1984b). 
The objective of this study was to attempt to isolate a specific peptide 
or amino acid (or several related amino acids and/or peptides) from the 
yeast GTF which would account for the total observed activity of the 
sample. 
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